Eli Lilly And Co receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Wells Fargo's analysts raised the firm's price target on Eli Lilly & Co. (NYSE:LLY) to $500 from $440, maintaining an Overweight rating on the stock in a note Friday. The analysts...
Teens and older adults at risk, say doctors and researchers, as Novo Nordisk’s Wegovy and Ozempic are hyped heavily online.
Dark sides of weight-loss-drug craze: risky knockoffs, eating disorders and more
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Thursday's top analyst upgrades and downgrades included Antero Resources, AutoZone, Coterra Energy, Dollar General, Eli Lilly, First Horizon, Infosys, Owens Corning, Palo Alto...
Bank of America reiterated a Buy rating on Eli Lilly & Co. (NYSE:LLY) and raised their 12-month price target on the stock to $500.00 (From $450.00) following a proprietary consumer...
TD Cowen raised its price target on Eli Lilly (NYSE:LLY) to $500.00 from $430.00 while maintaining an Outperform after the recent confirmatory data on tirzepatide in obesity and...